Nitto Denko

C3Nano is the developer of the solution-based, transparent conductive inks and films as direct replacements for indium tin oxide (ITO). C3Nano is the performance leader in Transparent Conductor Films (TCFs) and Activegrid silver nanowire (AgNW) solution-based inks for the touch sensor and display industry. They have raised $37 million in funding to date, which has enabled the company to quickly achieve best in class ink formulations and expanded production capabilities. C3Nano is headquartered in Silicon Valley with an industry-leading manufacturing base in Korea. Founded in 2010, it is headquartered in Hayward, California.

Algotochip revolutionizes the development of Digital chip (i.e: Systems on a Chip [SOCs]) by radically shortening the time and reducing the cost of the overall design process. This is made possible by their technology's ability to uniquely partition a customer's C-code into optimized modules that generate all the hardware and matched software components required for a complete solution to an application.

Altea Therapeutics Corporation develops and commercializes transdermal drug delivery systems. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The company also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. Altea Therapeutics Corporation was formerly known as Altea Development Corporation. The company was founded in 1998 and is based in Atlanta, Georgia. As of May 9, 2012, Altea Therapeutics Corporation operates as a subsidiary of Nitto Denko Corp.

Avecia is a leading private biotechnology company, operating through its OligoMedicines business, focused on the development and manufacture of innovative biotechnology-based medicines. With a long history of technological innovation, they work closely with their customers who are typically biotechnology or pharmaceutical companies, helping them achieve fast progress into, and through, the clinical development programme.